ClinVar Miner

Submissions for variant NM_000256.3(MYBPC3):c.3083C>T (p.Thr1028Ile) (rs397516002)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000766366 SCV000208147 uncertain significance not provided 2018-03-07 criteria provided, single submitter clinical testing The T1028I variant of uncertain significance in the MYBPC3 gene has been reported previously in three individuals with HCM, and was absent in 854 control alleles (Kapplinger et al., 2014). The T1028I variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The T1028I variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In addition, this substitution occurs at a position that is conserved in mammals. Consequently, in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, a missense variant in the same residue (T1028S) has been reported in association with HCM in a patient who also harbored a splice site variant on the other MYBPC3 allele (Morita et al., 2008). Additionally, variants in nearby residues (R1022C, R1022S, R1033W, R1033Q) have been reported in the Human Gene Mutation Database in association with cardiomyopathy (Stenson et al., 2014), supporting the functional importance of this residue and this region of the protein. Therefore, additional evidence is needed to determine whether this variant is pathogenic or benign.
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000151077 SCV000198821 uncertain significance not specified 2015-08-07 criteria provided, single submitter clinical testing The p.Thr1028Ile variant in MYBPC3 has been identified in 4 individuals with HCM (Kapplinger 2014, LMM unpublished data) and was absent from large population studies. Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the Thr1028Ile variant is uncertain.
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease,Montreal Heart Institute RCV000627167 SCV000748031 likely pathogenic Primary familial hypertrophic cardiomyopathy 2017-02-14 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.